/
MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%

Sector Heatmap

Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%

ANIP — ANI Pharmaceuticals, Inc.

Nasdaq

ANI Pharmaceuticals, Inc.

Back to Screener
$72.18
-0.78(-1.07%)
O
73.16
H
73.27
L
71.73
V
300.03K
⏱️ End-of-day dataAs of Oct 2, 2026
OverviewStatisticsFinancialsHistorical DataOptionsDividend HistoryNewsChart

ANI Pharmaceuticals, Inc. Statistics

Total Valuation

Market Cap$1.70B
Enterprise Value$1.73B

Important Dates

Earnings Daten/a
Ex-Dividend Daten/a

Share Statistics

Current Share Classn/a
Shares Outstanding22.96M
Shares Change (YoY)n/a
Shares Change (QoQ)n/a
Owned by Insiders (%)n/a
Owned by Institutions (%)n/a
Floatn/a

Valuation Ratios

PE Ratio56.39
Forward PEn/a
PS Ration/a
Forward PSn/a
PB Ratio29.46
P/TBV Ration/a
P/FCF Ratio36.13
P/OCF Ratio19.37
PEG Ration/a

Enterprise Valuation

EV / Earnings58.60
EV / Salesn/a
EV / EBITDA29.30
EV / EBIT39.28
EV / FCF36.73

Financial Position

Current Ratio3.12
Quick Ration/a
Debt / Equity1.06
Debt / EBITDA1.01
Debt / FCF1.26
Interest Coveragen/a

Financial Efficiency

Return on Equity (ROE)52.45%
Return on Assets (ROA)20.74%
Return on Invested Capital (ROIC)n/a
Return on Capital Employed (ROCE)n/a
Weighted Average Cost of Capital (WACC)n/a
Revenue Per Employeen/a
Profits Per Employee$30,404
Employee Count970
Asset Turnovern/a
Inventory Turnovern/a

Taxes

Income Tax$10.73M
Effective Tax Raten/a

Stock Price Statistics

Beta (5Y)n/a
52-Week Price Change-19.02%
50-Day Moving Average$75.31
200-Day Moving Average$78.51
Relative Strength Index (RSI)55.10
Average Volume (20 Days)407,038

Short Selling Information

Short Interestn/a
Short Previous Monthn/a
Short % of Shares Outn/a
Short % of Floatn/a
Short Ratio (days to cover)n/a

Income Statement

Revenuen/a
Gross Profit$14.39M
Operating Income$38.71M
Pretax Income$40.22M
Net Income$29.49M
EBITDA$58.97M
EBIT$43.99M
Earnings Per Share$1.28

Balance Sheet

Cash & Cash Equivalents$31.12M
Total Debt$59.45M
Net Cash-$28.33M
Net Cash Per Share$-1.23
Equity (Book Value)$56.23M
Book Value Per Share$2.45
Working Capital$50.76M

Cash Flow

Operating Cash Flow$87.74M
Capital Expenditures-$6.07M
Depreciation & Amortizationn/a
Net Borrowingn/a
Free Cash Flow$47.05M
FCF Per Share$2.05

Margins

Gross Marginn/a
Operating Marginn/a
Pretax Marginn/a
Profit Marginn/a
EBITDA Marginn/a
EBIT Marginn/a
FCF Marginn/a

Dividends & Yields

Dividend Per Sharen/a
Dividend Yieldn/a
Dividend Growth (YoY)n/a
Years of Dividend Growthn/a
Payout Ration/a
Buyback Yieldn/a
Shareholder Yieldn/a
Earnings Yield1.77%
FCF Yield2.77%

Analyst Forecast

Price Targetn/a
Price Target Differencen/a
Analyst Consensusn/a
Analyst Countn/a
Revenue Growth Forecast (3Y)n/a
EPS Growth Forecast (3Y)n/a

Fair Value

Lynch Fair Value$19.20
Lynch Upside-73.40%
Graham Number$8.40
Graham Upside-88.36%

Stock Splits

Last Split Daten/a
Split Typen/a
Split Ration/a

Scores

Altman Z-Scoren/a
Piotroski F-Scoren/a